Abstract |
Volatile anesthetics are known to have immunomodulatory effects in conditions of organ injury. A recent study in an experimental sepsis model has shown remarkably improved survival when mice were exposed to volatile anesthetics. In the present study, we show that hexafluoroisopropanol - a water-soluble primary sevoflurane metabolite - has beneficial effects on the overall survival in a murine model of cecal ligation and puncture. Seven-day survival as well as tissue damage markers including transaminases and high mobility group box protein-1 were assessed as measures of end organ damage. In animals undergoing cecal ligation and puncture procedure hexafluoroisopropanol conditioning - but not late postconditioning 24 hours after sepsis induction - significantly increased survival rate (17% vs. 77%, pā=ā0.037) and attenuated secretion of organ damage markers. This study shows survival benefits by administration of the metabolite of a volatile anesthetic. If successfully translated, hexafluoroisopropanol might offer interesting therapeutic opportunities in the future treatment of abdominal sepsis.
|
Authors | Inge K Herrmann, Maricela Castellon, David E Schwartz, Melanie Hasler, Martin Urner, Guochang Hu, Richard D Minshall, Beatrice Beck-Schimmer |
Journal | PloS one
(PLoS One)
Vol. 8
Issue 8
Pg. e72057
( 2013)
ISSN: 1932-6203 [Electronic] United States |
PMID | 23977207
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Biomarkers
- HMGB1 Protein
- HMGB1 protein, mouse
- Immunologic Factors
- Propanols
- hexafluoroisopropanol
- Transaminases
|
Topics |
- Administration, Intravenous
- Animals
- Biomarkers
(blood)
- Blood Urea Nitrogen
- Cecum
(pathology)
- Drug Evaluation, Preclinical
- HMGB1 Protein
(blood)
- Immunologic Factors
(administration & dosage)
- Kaplan-Meier Estimate
- Male
- Mice
- Mice, Inbred C57BL
- Peritonitis
(drug therapy, immunology, metabolism)
- Propanols
(administration & dosage)
- Sepsis
(drug therapy, immunology, metabolism)
- Transaminases
(blood)
- Treatment Outcome
|